CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $475,000 | +379.8% | 399,039 | +1827.2% | 0.06% | +293.8% |
| Q4 2020 | $99,000 | 0.0% | 20,706 | +32.9% | 0.02% | -36.0% |
| Q1 2020 | $99,000 | -51.2% | 15,576 | -20.0% | 0.02% | +4.2% |
| Q4 2019 | $203,000 | +89.7% | 19,482 | -28.3% | 0.02% | +71.4% |
| Q3 2019 | $107,000 | -91.3% | 27,178 | +94.1% | 0.01% | -70.2% |
| Q2 2015 | $1,230,000 | +162.8% | 14,000 | +121.9% | 0.05% | +147.4% |
| Q1 2015 | $468,000 | +37.6% | 6,309 | +11.9% | 0.02% | -29.6% |
| Q4 2013 | $340,000 | +11.8% | 5,637 | +12.7% | 0.03% | +12.5% |
| Q3 2013 | $304,000 | – | 5,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |